Nobilis Health receives ‘hold’ rating from Zacks: 6 points

Zacks rated Nobilis Health “hold,” with a rank of three, according to Founders Daily.

Advertisement

Here are six points:

1. Wall Street firms gave Nobilis a “strong buy.”

2. On June 21, Nobilis stock increased 12.39 percent.

3. Nobilis’ shares reached a high of $2.70 and a low of $2.24 during the June 21 trading session.

4. The company’s 52-week high is $7.80 and 52-week low is $1.82.

5. Nobilis has a market cap of $195 million.

6. Over the last three months, Nobilis stock has decreased 21.6 percent.

More articles on transactions & valuation:
Physician Realty Trust purchases Peak One Surgery Center in million-dollar transaction: 3 points
Regent Surgical Health names Chris Bishop CEO: 5 points
Will AmSurg exit the ASC business following its Envision Health merger? Cantor Fitzgerald analyst weighs in

At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.

Register to Attend Webinar

Is ambulatory care healthcare’s big margin engine? 4 leaders weigh in

Wednesday, July 29
1:00 PM - 2:00 PM CDT

Presenters: Joe Ganley, athenahealthJeffrey Flynn, CASC, Gramercy Surgery CenterBryan Tsao, Access Center, Loma Linda University HealthJason Zepeda, Northridge Hospital Medical Center, CommonSpirit HealthGreg DeConciliis, PA-C, CASC, Boston Out­Patient Surgical Suites

Advertisement

Next Up in ASC Transactions & Valuation Issues

Advertisement

Comments are closed.